Longevity Families of the Netherlands
LOF-NL
1 other identifier
observational
600
1 country
1
Brief Summary
The demographic life expectancy enhancement of the past 150 years imposes an urgent challenge in Western and economically growing societies to stimulate the healthy lifespan that is lagging behind. Families surviving into exceptionally high ages (longevity) in good physical and mental health illustrate that this is physiologically possible. Such families harbor cross generational socio-genetic mechanisms that mediate healthy aging and protection from (multi)morbidity. The purpose of our research is: to identify gene variants associated with healthy aging and protection from (multi)morbidity; to study the social-, environment- and behavioral factors of familial longevity, their role in (multi-)morbidity and its interaction with the genetic component.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 11, 2023
CompletedFirst Submitted
Initial submission to the registry
March 20, 2024
CompletedFirst Posted
Study publicly available on registry
April 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
April 18, 2024
April 1, 2024
3.2 years
March 20, 2024
April 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Identifying the genetic variants of Familial Longevity
To identify gene variants associated with healthy aging and protection from (multi)morbidity
through study completion, an average of 2 years
Secondary Outcomes (1)
Studying the environmental factor of Familial Longevity through questionnaires and its interaction with the genetic component
through study completion, an average of 2 years
Study Arms (2)
Cases - Enriched for familial longevity
Siblings of dutch Caucasian descent ages 75 and older
Controls - Non-enriched for familial longevity
Individuals of dutch Caucasian descent ages 75 and older solely in their family.
Eligibility Criteria
Dutch Caucasian descent: Ages 75 and older, with siblings enriched for familial longevity, and individuals without a history of familial longevity
You may qualify if:
- Siblings of Dutch Caucasian descent age 75+ enriched for familial longevity
- Individuals of Dutch Caucasian descent age 75+ who are not enriched for familial longevity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Leiden University Medical Centerlead
- Jacobijn Gussekloo, Prof. dr.collaborator
- Simon P. Mooijaart, Prof. dr.collaborator
Study Sites (1)
Leiden University Medical Center
Leiden, South Holland, 2333ZA, Netherlands
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Eline Slagboom, Prof. dr.
Study Record Dates
First Submitted
March 20, 2024
First Posted
April 18, 2024
Study Start
September 11, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
April 18, 2024
Record last verified: 2024-04